MSB 7.69% $1.19 mesoblast limited

Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial, page-75

  1. 82 Posts.
    lightbulb Created with Sketch. 6
    I guess FDA does not provide more information... 45% will be out soon...
  2. 10 Posts.
    lightbulb Created with Sketch. 238
    The results from the interim analysis will not be released while the trial continues, which is standard practice. Releasing the results would be a confounding factor and introduce bias to those involved in the rest of the trial.
    Last edited by NuitsSonores: 04/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.